p21cip1 degradation in differentiated keratinocytes is abrogated by costabilization with cyclin E induced by human papillomavirus E7

Journal of Virology

Volumn 75, Issue 13, 2001, Pages 6121-6134

  Noya, F ^a   Chien, W M ^a   Broker, T R ^a   Chow, L T ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN E; LACTACYSTIN; PROTEASOME; PROTEIN KINASE C INHIBITOR; VIRUS PROTEIN;

ARTICLE; CELL CYCLE S PHASE; CELL DIFFERENTIATION; COMPLEX FORMATION; CONTROLLED STUDY; DNA REPLICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; KERATINOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN STABILITY; WART VIRUS;

ACETOPHENONES; ACETYLCYSTEINE; ANIMALS; BENZOPYRANS; CYCLIN E; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; CYSTEINE ENDOPEPTIDASES; DNA-BINDING PROTEINS; HUMANS; INFANT, NEWBORN; KERATINOCYTES; MULTIENZYME COMPLEXES; ONCOGENE PROTEINS, VIRAL; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN KINASE C; RABBITS;

EID: 0034979115     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.13.6121-6134.2001     Document Type: Article

References (83)

1. Cyclin E and c-Myc promote cell proliferation in the presence of p16INK4a and of hypophosphorylated retinoblastoma family proteins
2. Differential regulation of the pocket domains of the retinoblastoma family proteins by the HPV16 E7 oncoprotein
3. Retinoblastoma protein recruits histone deacetylase to repress transcription
4. Effects of p21Waf1/Cip1/Sdi1 on cellular gene expression: Implications for carcinogenesis, senescence, and age-related diseases
5. Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA
6. Differentiation-dependent up-regulation of the human papillomavirus E7 gene reactivates cellular DNA replication in suprabasal differentiated keratinocytes
7. Casein kinase II phosphorylation of the human papillomavirus-18 E7 protein is critical for promoting S-phase entry
8. Small DNA tumor viruses
9. Functional interaction between the bovine papillomavirus virus type 1 replicative helicase E1 and cyclin E-Cdk2
10. Transforming growth factor β induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism
11. Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control
12. Specific protein kinase C isozymes mediate the induction of keratinocyte differentiation markers by calcium
13. Inhibitory function of p21Cip1/WAF1 in differentiation of primary mouse keratinocytes independent of cell cycle control
14. The regulation of E2F by pRB-family proteins
15. Lactacystin, proteasome function, and cell fate
16. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice
17. Cdk-interacting protein 1 directly binds with proliferating cell nuclear antigen and inhibits DNA replication catalyzed by the DNA polymerase delta holoenzyme
18. Protein kinase C isozyme-mediated cell cycle arrest involves induction of p21 (waf1/cip1) and p27(kip1) and hypophosphorylation of the retinoblastoma protein in intestinal epithelial cells
19. Inhibition of CDK activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7 oncoprotein
20. Regulation of cyclin E transcription by E2Fs and retinoblastoma protein
21. Rottlerin, a novel protein kinase inhibitor
22. Cyclin E2, a novel G1 cyclin that binds Cdk2 and is aberrantly expressed in human cancers
23. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD
24. Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1
25. Complete inhibition of Cdk/cyclin by one molecule of p21 (Cip1)
26. Cyclin-dependent kinase and initiation at eukaryotic origins: A replication switch?
27. Post-transcriptional induction of p21cip1 protein by human papillomavirus E7 inhibits unscheduled DNA synthesis reactivated in differentiated keratinocytes
28. Concordant induction of cyclin E and p21cip1 in differentiated keratinocytes by the human papillomavirus E7 protein inhibits cellular and viral DNA synthesis
29. The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21Cip1-mediated inhibition of cdk2
30. Destabilization of the KB tumor suppressor protein and stabilization of p53 contribute to HPV type 16 E7-induced apoptosis
31. Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1)
32. Negative regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinase
33. Cyclin E2: A novel CDK2 partner in the late G1 and S phases of the mammalian cell cycle
34. S-phase entry upon ectopic expression of G1 cyclin-dependent kinases in the absence of retinoblastoma protein phosphorylation
35. Collaborative role of E2F transcriptional activity and G1 cyclin dependent kinase activity in the induction of S phase
36. HeLa cells are phenotypically limiting in cyclin E/CDK2 for efficient human papillomavirus DNA replication
37. Cyclin E-induced S phase without activation of the pRb/E2F pathway
38. Rb interacts with histone deacetylase to repress transcription
39. NPAT by cyclin E/Cdk2 in Cajal bodies promotes histone gene transcription
40. Interaction between cyclin-dependent kinases and human papillomavirus replication-initiation protein E1 is required for efficient viral replication
41. p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage
42. Retinoblastoma protein represses transcription by recruiting a histone deacetylase
43. Human Cdc7-related kinase complex. In vitro phosphorylation of MCM by concerted actions of Cdks and Cdc7 and that of a critical threonine residue of Cdc7 by Cdks
44. Improved retroviral vectors for gene transfer and expression
45. Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation
46. Cell cycle-dependent phosphorylation of p27 cyclin-dependent kinase (Cdk) inhibitor by cyclin E/Cdk2
47. Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors
48. Targeted disruption of Skp2 results in accumulation of cyclin E and p27(Kip1), polyploidy and centrosome overduplication
49. 1 cyclin-dependent kinase inhibitor, is dependent on CDK2 activity and the proteasome
50. 2/M cell cycle transitions: pRb is a critical determinant in blocking DNA replication and in preventing endoreduplication
51. Induction of differentiation in normal human keratinocytes by adenovirus-mediated introduction of the eta and delta isoforms of protein kinase C
52. Regulation of the cyclin E gene by transcription factor E2F1
53. 1-to-S phase transition
54. Role of the ubiquitinproteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27
55. Mutational analyses of differentiation-dependent human papillomavirus type 18 enhancer elements in epithelial raft cultures of neonatal foreskin keratinocytes
56. p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells
57. Initiation of DNA synthesis by human papillomavirus E7 oncoproteins is resistant to p21-mediated inhibition of cyclin E-cdk2 activity
58. Human papillomavirus oncoproteins alter differentiation-dependent cell cycle exit on suspension in semisolid medium
59. 1/S-promoting mechanism parallel to the pRb/E2F pathway
60. Post-transcriptional induction of p21cip1 protein in condylomata and dysplasias is inversely related to human papillomavirus activities
61. Cyclin E-CDK2 is a regulator of p27Kip1
62. Proteasomal turnover of p21(Cip1) does not require p21(Cip1) ubiquitination
63. CDK inhibitors: Positive and negative regulators of G1-phase progression
64. Down-regulation of p27(Kip1) by two mechanisms, ubiquitin-mediated degradation and proteolytic processing
65. Cullin-3 targets cyclin E for ubiquitination and controls S phase in mammalian cells
66. Leaky scanning is the predominant mechanism for translation of human papillomavirus type 16 E7 oncoprotein from E6/E7 bicistronic mRNA
67. Viral E6-E7 transcription in the basal layer of organotypic cultures without apparent p21cip1 protein precedes immortalization of human papillomavirus type 16- and 18-transfected human keratinocytes
68. The role of the E6-p53 interaction in the molecular pathogenesis of HPV
69. Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27
70. Cell cycle-dependent regulation of human DNA polymerase alpha-primase activity by phosphorylation
71. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA
72. An alpha-mercaptoacrylic acid derivative is a selective nonpeptide cell-permeable calpain inhibitor and is neuroprotective
73. Culprits in the degradation of cyclin E apprehended
74. Cyclin E2, a novel human G1 cyclin and activating partner of CDK2 and CDK3, is induced by viral oncoproteins
75. Overriding of cyclin-dependent kinase inhibitors by high and low risk human papillomavirus types: Evidence for an in vivo role in cervical lesions
76. Regulation of p21WAF1/CIP1 expression by p53-independent pathways
77. Inactivation of the cdk inhibitor p27KIP1 by the human papillomavirus type 16 E7 oncoprotein
78. Sequential activation of cyclin E and cyclin A gene expression by human papillomavirus type 16 E7 through sequences necessary for transformation
79. The cyclin-dependent kinase inhibitor p21cip1 mediates the growth inhibitory effect of phorbol esters in human venous endothelial cells
80. NPAT links cyclin E-Cdk2 to the regulation of replication-dependent histone gene transcription
81. Papillomaviruses causing cancer: Evasion from host-cell control in early events in carcinogenesis
82. Cell transformation by the E7 oncoprotein of human papillomavirus type 16: Interactions with nuclear and cytoplasmic target proteins